FunXtion is a technology company.
FunXtion has raised $6.0M across 1 funding round.
FunXtion has raised $6.0M in total across 1 funding round.
FunXtion has raised $6.0M in total across 1 funding round.
FunXtion's investors include Lexar Partners.
Function Health (often stylized as Function) is a health technology company building an operating system for human health, offering membership-based access to over 160 lab tests, advanced MRI and CT scans, and AI-driven insights to empower proactive health management.[1][2][3] It serves hundreds of thousands of direct-to-consumer members seeking early disease detection, personalized medicine, and longevity, solving the problem of fragmented, reactive healthcare by providing comprehensive, understandable biological data and clinical summaries shareable with physicians.[1][2] With a $2.5B valuation after a $298M oversubscribed Series B in November 2025, Function has strong growth momentum, including over 3 million lab tests in 2023, 100,000+ members by 2024, and recognition as a TIME100 Most Influential Company.[1][2]
Function Health was founded in 2021 in Austin, Texas, by a team motivated by personal health challenges and frustrations with traditional medicine's reactive approach.[2][3] Key co-founders include Mark Hyman (Chief Medical Officer, academic medicine veteran advocating proactive health), Pranitha Patil (Chief Business Officer, former Accenture Health Strategy consultant managing PCOS), Mike Nemke (CTO, serial entrepreneur), Seth Weisfeld (Chief Design Officer, UX expert with autoimmune issues), and brothers Jonathan Swerdlin (CEO, Ezra CEO post-acquisition) and Daniel Swerdlin.[2][3][4] The idea emerged from founders' experiences—like Hyman's shift from symptom-chasing to biomarker optimization, Patil's blood sugar reversal, and Swerdlin's mission for early cancer detection after his mother's late diagnosis—aiming to make advanced testing as routine as checkups.[3] Early traction built via popular lab memberships; pivotal moments include 2025's Ezra acquisition for MRI/CT integration, Mother's Day campaign, Academy Awards gift bag inclusion, and TIME recognition.[1][2]
Function rides the longevity and personalized medicine wave, capitalizing on AI, big data, and consumer demand for proactive health amid rising chronic disease burdens.[1][2] Timing aligns with post-pandemic health awareness, AI advancements in diagnostics, and skepticism toward fragmented systems—evidenced by its rapid scaling to millions of tests and $2.5B valuation.[1][6] Market forces like aging populations, biomarker tech maturity, and direct-to-consumer shifts (e.g., similar to Ro or Virta Health) favor it, while influencing the ecosystem by redefining standards: normalizing advanced scans, aggregating health OS data, and pressuring incumbents toward prevention over reaction.[1][4][6]
Function is poised to expand its Medical Intelligence Lab, integrating more AI for predictive analytics and global scaling, potentially onboarding waitlisted users and new modalities amid longevity trends.[1][6] Rising AI-health convergence and evidence-building for its tests could solidify category leadership, though regulatory scrutiny on low-risk screenings looms.[6] Its influence may evolve from consumer darling to ecosystem enabler, partnering with insurers or pharma, ultimately making "100 healthy years" the new health baseline—as it fuses tech with medicine to empower proactive control.[1]
FunXtion has raised $6.0M across 1 funding round. Most recently, it raised $6.0M Series A in August 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2022 | $6.0M Series A | Lexar Partners |